ID

27395

Descripción

PF-00299804 As A Single Agent, In Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Chemotherapy And Erlotinib; ODM derived from: https://clinicaltrials.gov/show/NCT00548093

Link

https://clinicaltrials.gov/show/NCT00548093

Palabras clave

Versiones (1)
  1. 13/11/17 13/11/17 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

13 de noviembre de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Carcinoma, Non Small Cell Lung NCT00548093

Inglés

Eligibility Carcinoma, Non Small Cell Lung NCT00548093

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
advanced non-small cell lung cancer (nsclc)
Descripción

Non-Small Cell Lung Carcinoma Advanced

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C0205179
prior treatment with and failure of at least one regimen of chemotherapy and erlotinib.
Descripción

Chemotherapy Regimen Quantity failed | erlotinib

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0231175
UMLS CUI [2]
C1135135
prior treatment with no more than two chemotherapy regimens, including adjuvant or combined modality treatment.
Descripción

Chemotherapy Regimen Quantity | Chemotherapy, Adjuvant | Combined Modality Therapy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1265611
UMLS CUI [2]
C0085533
UMLS CUI [3]
C0009429
measurable disease .
Descripción

Measurable Disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1513041
eastern cooperative oncology group (ecog) performance status 0-2
Descripción

ECOG performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
tissue available for kras/ egfr testing
Descripción

Tissue Available kras gene (procedure) | Tissue Available egfr gene (procedure)

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1292533
UMLS CUI [1,2]
C0470187
UMLS CUI [1,3]
C3537133
UMLS CUI [2,1]
C1292533
UMLS CUI [2,2]
C0470187
UMLS CUI [2,3]
C3497772
creatinine clearance > 40 cc/min or serum creat < 1.5 x uln
Descripción

Creatinine clearance measurement | Creatinine measurement, serum

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0373595
UMLS CUI [2]
C0201976
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
chemotherapy
Descripción

Chemotherapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0392920
radiotherapy
Descripción

Therapeutic radiology procedure

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1522449
biological or investigational agents within 4 weeks of baseline disease assessment.
Descripción

Biological Factors | Investigational New Drugs

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0005515
UMLS CUI [2]
C0013230
patients who lack of tolerance of erlotinib therapy.
Descripción

Intolerance to erlotinib

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1744706
UMLS CUI [1,2]
C1135135
Volver a la parte superior de la página

Similar models

Eligibility Carcinoma, Non Small Cell Lung NCT00548093

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Non-Small Cell Lung Carcinoma Advanced
Item
advanced non-small cell lung cancer (nsclc)
boolean
C0007131 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
Chemotherapy Regimen Quantity failed | erlotinib
Item
prior treatment with and failure of at least one regimen of chemotherapy and erlotinib.
boolean
C0392920 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0231175 (UMLS CUI [1,3])
C1135135 (UMLS CUI [2])
Chemotherapy Regimen Quantity | Chemotherapy, Adjuvant | Combined Modality Therapy
Item
prior treatment with no more than two chemotherapy regimens, including adjuvant or combined modality treatment.
boolean
C0392920 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0085533 (UMLS CUI [2])
C0009429 (UMLS CUI [3])
Measurable Disease
Item
measurable disease .
boolean
C1513041 (UMLS CUI [1])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status 0-2
boolean
C1520224 (UMLS CUI [1])
Tissue Available kras gene (procedure) | Tissue Available egfr gene (procedure)
Item
tissue available for kras/ egfr testing
boolean
C1292533 (UMLS CUI [1,1])
C0470187 (UMLS CUI [1,2])
C3537133 (UMLS CUI [1,3])
C1292533 (UMLS CUI [2,1])
C0470187 (UMLS CUI [2,2])
C3497772 (UMLS CUI [2,3])
Creatinine clearance measurement | Creatinine measurement, serum
Item
creatinine clearance > 40 cc/min or serum creat < 1.5 x uln
boolean
C0373595 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Chemotherapy
Item
chemotherapy
boolean
C0392920 (UMLS CUI [1])
Therapeutic radiology procedure
Item
radiotherapy
boolean
C1522449 (UMLS CUI [1])
Biological Factors | Investigational New Drugs
Item
biological or investigational agents within 4 weeks of baseline disease assessment.
boolean
C0005515 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
Intolerance to erlotinib
Item
patients who lack of tolerance of erlotinib therapy.
boolean
C1744706 (UMLS CUI [1,1])
C1135135 (UMLS CUI [1,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial